ocrelizumabnatalizumabofatumumabrituximabmAb-BFDMTmultiple sclerosisneuromyelitis optica spectrum disorderGerman MS and Pregnancy Registrydisease-modifying therapy
…nfants, most were breastfed on natalizumab (n=125), followed by ocrelizumab (n=34), rituximab (n=11) and ofatumumab (n=10); three had multi…